U.S. Withdrawal from WHO: Implications and Background

In a recent move, President Trump signed an executive order announcing the United States' withdrawal from the World Health Organization (WHO). This marks a repeat action, as Trump had previously initiated the exit process during his first term.

Historical Context

On July 6, 2020, the Trump administration formally notified UN Secretary-General Antonio Guterres of its intent to leave the WHO, with an effective exit date set for July 6, 2021. This decision faced significant backlash both internationally and domestically. However, upon taking office in 2021, President Biden reversed the withdrawal, reaffirming the U.S. commitment to the organization.

Reasons for Withdrawal

The recent executive order cites two primary reasons for the exit:

Ineffectiveness in Handling COVID-19: The White House criticized WHO for its inadequate response to the COVID-19 pandemic, asserting that the organization failed to provide timely and appropriate measures.

Excessive Membership Fees: The administration expressed concerns over what it deemed unfairly high membership fees demanded by WHO, which were perceived as disproportionate compared to other countries' contributions.

Furthermore, Trump announced that the U.S. would suspend all government funding or resources to WHO moving forward.

Potential Impacts

According to WHO's official website, the organization has two primary funding sources: assessed contributions (membership fees) and voluntary donations. The assessed contributions account for less than 25% of WHO's budget, with the remainder obtained through voluntary donations from member states and other partners.

In addition to contributing approximately $110 million annually in assessed fees, the U.S. has been a leading voluntary donor, contributing $1.1 billion between 2022 and 2023. Overall, the U.S. has provided around 20% of WHO's total budget.

Experts, such as global health specialist Ilona Kickbusch, warn that the consequences of the U.S. withdrawal could be significant. The departure will sever connections between WHO and key U.S. health institutions, including the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Virologist Marion Koopmans from the Erasmus Medical Center in the Netherlands remarked, “The U.S. exit will impede the CDC’s access to critical intelligence vital for global safety.”

The U.S. withdrawal from WHO not only raises concerns about future global health cooperation but also highlights the ongoing tensions surrounding international health governance. As the world continues to navigate public health crises, the absence of U.S. leadership in WHO could have far-reaching effects on global health initiatives.